Banque Pictet & Cie Sa Eli Lilly & CO Transaction History

Banque Pictet & Cie Sa

$14.9 Billion
Q4 2024

A detailed history of Banque Pictet & Cie Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 81,981 shares of LLY stock, worth $67.6 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

81,981

Previous 66,964 22.43%

Holding current value

$67.6 Million

Previous $59.3 Million 6.68%

% of portfolio

0.42%

Previous 0.45%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$727.2 - $932.06 $10.9 Million - $14 Million	15,017 Added 22.43%	81,981 $63.3 Million
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $1.85 Million - $2.29 Million	2,390 Added 3.7%	66,964 $59.3 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $1.26 Million - $1.58 Million	1,735 Added 2.76%	64,574 $58.5 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $1.25 Million - $1.68 Million	-2,119 Reduced 3.26%	62,839 $48.9 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $28.5 Million - $33.6 Million	-54,286 Reduced 45.53%	64,958 $37.9 Million
Q3 2023 Nov 27, 2023	SELL	$434.7 - $599.3 $1.74 Million - $2.4 Million	-4,000 Reduced 3.25%	119,244 $64 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $2.08 Million - $2.87 Million	-4,796 Reduced 3.75%	123,244 $66.2 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $11.4 Million - $15.3 Million	32,606 Added 34.17%	128,040 $60 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $14.7 Million - $17.2 Million	47,165 Added 97.71%	95,434 $32.8 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $11.1 Million - $12.9 Million	-34,517 Reduced 41.69%	48,269 $0
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $753,059 - $858,189	2,540 Added 3.17%	82,786 $26.8 Billion
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $2.2 Million - $2.58 Million	-7,895 Reduced 8.96%	80,246 $26 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $9,152 - $11,374	39 Added 0.04%	88,141 $25.2 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $9.83 Million - $12.2 Million	43,737 Added 98.58%	88,102 $24.3 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $620,036 - $763,042	-2,798 Reduced 5.93%	44,365 $10.3 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $5.68 Million - $7.35 Million	31,463 Added 200.4%	47,163 $10.8 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $492,960 - $638,160	-3,000 Reduced 16.04%	15,700 $2.93 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $117,414 - $155,367	-900 Reduced 4.59%	18,700 $3.16 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $272,840 - $328,360	-2,000 Reduced 9.26%	19,600 $3.22 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $89,287 - $110,512	-750 Reduced 3.36%	21,600 $3 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $144,342 - $178,780	1,350 Added 6.43%	22,350 $2.94 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $2.24 Million - $2.61 Million	-20,200 Reduced 49.03%	21,000 $2.33 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $556,550 - $655,100	-5,000 Reduced 10.82%	41,200 $5.35 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $225,037 - $252,110	-2,125 Reduced 4.4%	46,200 $5.35 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $3.74 Million - $4.68 Million	-43,575 Reduced 47.42%	48,325 $5.19 Million
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $3.06 Million - $3.52 Million	-40,472 Reduced 30.57%	91,900 $7.84 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $315,392 - $372,300	-4,250 Reduced 3.11%	132,372 $10.2 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $600,702 - $644,321	-7,331 Reduced 5.09%	136,622 $11.5 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $1.49 Million - $1.65 Million	19,293 Added 15.48%	143,953 $12.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	124,660	124,660 $10.3 Million

Others Institutions Holding LLY

# of Institutions

4,287

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $784B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Eli Lilly & CO Transaction History